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Effect of pooling samples on the efficiency of comparative studies using microarrays
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MRC Toxicology Unit, Hodgkin Building, Lancaster Road, University of Leicester, Leicester, UK
Many biomedical experiments are carried out by pooling individual biological samples. However,
pooling samples can potentially hide biological variance and give false confidence concerning the
data significance. In the context of microarray experiments for detecting differentially expressed
genes, recent publications have addressed the problem of the efficiency of sample-pooling, and some
approximate formulas were provided for the power and sample size calculations. It is desirable to
have exact formulas for these calculations and have the approximate results checked against the
exact ones. We show that the difference between the approximate and exact results can be large.
In this study, we have characterized quantitatively the effect of pooling samples on the efficiency
of microarray experiments for the detection of differential gene expression between two classes.
We present exact formulas for calculating the power of microarray experimental designs involving
sample pooling and technical replications. The formulas can be used to determine the total numbers
of arrays and biological subjects required in an experiment to achieve the desired power at a given
significance level. The conditions under which pooled design becomes preferable to non-pooled
design can then be derived given the unit cost associated with a microarray and that with a biological
subject. This paper thus serves to provide guidance on sample pooling and cost effectiveness. The
formulation in this paper is outlined in the context of performing microarray comparative studies,
but its applicability is not limited to microarray experiments. It is also applicable to a wide range
of biomedical comparative studies where sample pooling may be involved.
A Java Webstart application can be accessed at http://wads.le.ac.uk/htox/WadsSoftware
/MrcStats/SCal4Poolings.jnlp
I. INTRODUCTION
Pooling samples in biomedical studies has now become
a frequent practice among many researchers. For exam-
ple, more than 15% of the data sets deposited in the
Gene Expression Omnibus Database involve pooled RNA
samples[1]. The practice of pooling biological samples
though is not a new phenomenon, as it can be traced
back at least to 1940s [2] and has been used in differ-
ent application areas [3], e.g., for the detection of certain
medical conditions and estimation of prevalence in a pop-
ulation. In the context of detecting differential gene ex-
pressions using microarrays, divergent views on the wis-
dom of pooling samples can be found in the literature
[4, 5, 6, 7, 8, 9]. One of the arguments supporting the
practice of pooling biological samples is that biological
variation can be reduced by pooling RNA samples in mi-
croarray experiments[6]. As more carefully described by
Kendziorski et al [1], pooling can reduce the effects of
biological variation, but not the biological variation it-
self. Another argument in support of pooling samples in
microarray experiments is that it reduces financial cost.
However, cost reduction is meaningful only if statistical
equivalence between the pooled and the non-pooled ex-
perimental setups is maintained. Here we address this
issue and present formulas to determine the conditions
under which pooled and non-pooled designs are statisti-
cally equivalent.
To compare experimental designs with and without
sample pooling the two designs must have something
in common that can be measured, e.g., using the same
or equivalent amount of resources, or, yielding the same
level of detection power. Kendziorski et al[10] used the
width of the 95% confidence interval for gene expression
to compare different experimental designs with and with-
out sample pooling. The criterion was that the narrower
the confidence interval, the more accurate the results
from the experimental design. In a comparative study
where two groups of biological subjects are compared
the common goal of the different experimental designs is
to detect a change between the two groups with a given
power at a given false positive rate, as adopted in [9]. We
shall use the latter method to compare different designs.
So in this work statistical equivalence means that the de-
signs have the same statistical power at the same level
of significance. Therefore the more appropriate experi-
mental design will be the one which uses less resources
to achieve this statistical equivalence.
The basic assumption underlying sample pooling is bi-
ological averaging; that the measure of interest taken on
the pool of samples is equal to the average of the same
measure taken on each of the individual samples which
contributed to the pool. For example in the situation
of a microarray experiment, if r individual samples con-
tribute equally to a pool, and the concentrations of a
gene’s mRNA transcripts for the r samples are denoted
by Ti with i = 1, 2, · · · , r indexing the individual samples,
the assumption of biological averaging says that the con-
centration of this gene’s mRNA transcripts in the pool
is T = 1/r
∑r
i=1 Ti. However, for microarray experiment
there is some debate on whether the basic assumption
of pooling holds. Kendziorski et al [1, 10] argue that
there is limited support for this assumption. Here we
do not seek to enter into this debate but rather take the
assumption of biological averaging as valid, or at least
approximately so, so that we are in a position to deter-
2mine whether pooling samples is financially beneficial or
not. The validity of biological averaging makes it possible
(or easier) to derive a neat theoretical formulation. On a
practical level though, the requirement for the validity of
this assumption may not be as stringent as a theoretical
formulation does. For instance, in [1] it was shown that
even when biological averaging does not hold, pooling
can be useful and inferences regarding differential gene
expression are not adversely affected by pooling.
One situation where there is little alternative but
to pool biological samples is where there is insufficient
amount of RNA from each individual biological subject
to perform single microarray hybridization. RNA ampli-
fication may be a possible way of obtaining more RNA,
but may not be practically feasible when many individ-
ual biological subjects are involved as in the case of [11].
In such a circumstance, pooling samples is justified by
the lack of alternative and will not be considered further
here. Similarly we will not consider here the case where
all the biological samples of the same group were pooled
together, and multiple technical replicate measurements
were carried out on the sample pool. This is sometimes
seen in the literature [12], but such an experimental de-
sign leaves no degree of freedom to estimate the biological
variance. Thus valid inferences about the differences be-
tween the two populations of biological subjects under
study cannot be made. Here we only consider situations
other than the above two and where pooling may reduce
the overall costs of the experiments.
II. A GENERAL FORMALISM
For every comparative study, there is at least one mea-
surable quantity which is the quantity of interest. The
goal of the study is to deduce from the data collected
if there is any difference between the means of the two
populations. As measuring all the biological subjects in
two populations is rarely possible in most situations rep-
resentatives from a population are randomly selected and
measurements made on these. These are then taken to
infer the properties of the population.
Let X be the measurable quantity that is being deter-
mined in the the experiment, e.g., the expression level of
a gene. In the case of one-channel microarray, X could
denote the logarithm (most commonly base 2 is used)
of fluorescence intensity; or the logarithm of the fluores-
cence ratio in the case of two-channel microarray. Let
xci denote the value of X for an individual subject i in
the control population (c), and xtj that of the individual
subject j in the treatment population (t). We assume
that xci s for all individuals in the control population are
independent normally distributed with a mean µc and a
variance σ2c , denoted by x
c
i ∼ N(µc, σ2c ) for all i. Simi-
larly, xtj ∼ N(µt, σ2t ) for all j.
A. A general experimental setup
For a general experimental setup individual subjects
from both populations are randomly selected and tissue
samples collected from each. Tissue sample pools are
made by pooling a given number r of randomly selected
tissue samples (of the same population) together. Note
that to make n pools we need to have selected nr individ-
ual subjects from the population. m measurements are
then made on each pool of tissue samples. So m is the
number of technical replications of measurement on each
pool. Notice that by introducing two parameters r and
m a general and flexible experimental setup has been cre-
ated. For instance, if we set r = 1, the experiment would
be equivalent to no pooling of tissue samples. And if
we set m = 1 there is no technical replication. Under
the basic assumption of biological averaging, the result
of pooling r tissue samples in equal proportions together
is that the value of X for the pool is the average of those
subjects which formed this pool,
x˜ =
1
r
r∑
i=1
xi. (1)
It follows that x˜ ∼ N(µc, σ2c/r) for a pool from the con-
trol population, or x˜ ∼ N(µt, σ2t /r) for a pool from the
treated population. Note that in this paper we shall
only discuss pooling samples with equal individual con-
tributions. While pools formed by un-equal contributions
from individual samples are possible, such pooled exper-
imental design is generally less effective than the equal
pooling, as already shown by Peng et al [8] with their
simulated results.
When we take a measurement on a pool p, the mea-
sured value is
yp,k = x˜p + ǫk, (2)
where p indexes pools, k indexes measurements, and ǫk
is a random error term assumed to be independently and
normally distributed as ǫk ∼ N(0, σ2ǫ ). Hereafter σ2ǫ will
be referred to as the technical variance, σ2c the biological
variance for the control population, and σ2t the biological
variance for the treatment population.
The output of the experiment are the measurements
on the two sets of pools. For the control group, we
have ycp,k for p = 1, . . . , nc and k = 1, . . . ,m. And for
the treatment group, we have ytp,k for p = 1, . . . , nt and
k = 1, . . . ,m. Here nc and nt are the numbers of pools
prepared for the control and treatment population re-
spectively. Our task is to infer population properties
from these measured data. In particular, we want to
know whether there is any difference between the two
populations means µc and µt. It can be shown that
Y
c
=
1
mnc
nc∑
p=1
m∑
k=1
ycp,k (3)
3is an unbiased estimator of µc, with a variance
1
nc
(
σ2c
r
+
σ2ǫ
m
)
, (4)
and similarly,
Y
t
=
1
mnt
nt∑
p=1
m∑
k=1
ytp,k (5)
is an unbiased estimator of µt, with a variance
1
nt
(
σ2t
r
+
σ2ǫ
m
)
. (6)
If we make an additional assumption that the variances
for the two populations of biological subjects are the
same, i.e., σ2c = σ
2
t = σ
2, then the difference between
Eqs.(5) and (3), D = Y
t − Y c, is an unbiased estimator
of µ = µt − µc with a variance
σ2D =
(
1
nc
+
1
nt
)(
σ2
r
+
σ2ǫ
m
)
. (7)
The factor (σ2/r + σ2ǫ/m) in Eq.(7) can be estimated
without bias by
s2p =
1
nc + nt − 2
nc∑
p=1
(
1
m
m∑
k=1
ycp,k − Y
c
)2
+
1
nc + nt − 2
nt∑
p=1
(
1
m
m∑
k=1
ytp,k − Y
t
)2
. (8)
It is then clear that
t =
(Y
t − Y c)− (µt − µc)
sp
√
1/nc + 1/nt
(9)
follows the Student’s t distribution with nc + nt − 2 de-
grees of freedom. In detecting a differential gene expres-
sion, we want to test the null hypothesis µc = µt against
an alternative hypothesis µc 6= µt. So our test statistic
is
t0 =
(Y
t − Y c)
sp
√
1/nc + 1/nt
, (10)
and there are no unknowns in Eq.(10). Note that t0
can be seen as a generalized two-sample-t-test statis-
tic, which reduces to the statistic of the traditional two-
sample t test with equal variance when we set the pa-
rameters r = 1 (no pooling of tissue samples) and m = 1
(no technical replication of measurements). In Ref. [9],
Shih et al. arrived at two separate statistics, one for non-
pooled design, the other for pooled design. The t0 defined
by Eq.(10) is in more general form, setting r = 1 and
m = 1 in Eq.(10) recovers Shih et al’s statistic for non-
pooled design; while setting r > 1 and m = 1 recovers
Shih et al’s statistic for pooled design. Note that m does
not need to equal 1. Here by incorporating two additional
parameters r and m, the statistic t0 can deal with situa-
tions where there are pooled tissue samples and multiple
technical replications.
B. Criteria of significance
As with any statistical test we need to specify a thresh-
old p-value Pth to claim significant results in the test.
When all the other parameters are given, setting Pth is
equivalent to setting a threshold, say |ξ|, for the statis-
tics t0 defined in Eq.(10). With this threshold t-value,
our criteria for claiming a significant test is as follows: If
t0 > |ξ|, we declare that µt − µc > 0; if t0 < −|ξ|, it is
claimed as µt−µc < 0. So the rate at which false positive
claims are made is
Pth =
∫ −|ξ|
−∞
ρnc+nt−2(t0)dt0 +
∫ ∞
|ξ|
ρnc+nt−2(t0)dt0
= 2
∫ −|ξ|
−∞
ρnc+nt−2(t0)dt0 = 2Tnc+nt−2(−|ξ|),(11)
where ρnc+nt−2(.) is the probability density function
(PDF) of the Student’s t distribution with nc + nt − 2
degrees of freedom, and Tnc+nt−2(.) is the corresponding
cumulative probability distribution function (CDF). It is
therefore apparent that the threshold t-value |ξ| can be
obtained by solving the equation 2Tnc+nt−2(−|ξ|) = Pth
with a given false positive rate Pth.
III. POWER FUNCTION
In [13] we presented a power function for a new statisti-
cal t test (hereafter referred to as ”two-labelling t test”)
in the context of using two-color microarrays to detect
differential gene expression. Following similar steps we
can derive the power function for the generalized two-
sample t test presented in this paper, which reads
S =
∫ ∞
0
pnc+nt−2(Y )Φ
[
−|ξ|√Y√
nc + nt − 2
+
|µ|
σD
]
dY, (12)
where pnc+nt−2(Y ) is the PDF for the χ
2 distribution
with nc + nt − 2 degrees of freedom, and Φ(.) is the
CDF for the standard normal distribution. The rate S
at which a true difference between µt and µc can be suc-
cessfully detected is a function of nc, nt, |µ|/σD, and
|ξ|. With σD given by the square root of Eq.(7), and |ξ|
determined by solving Eq.(11) at a given false positive
rate Pth, S is, eventually, a function of Pth, nc, nt, and
|µ|/σD.
A few points are worth noting here.
1. The two-labelling t test presented in [13] was de-
signed to deal with systematic labelling biases generated
4during microarray experimentation. The t test presented
in this paper, however, assumes no systematic data bi-
ases. In the case of two-color microarrays this requires a
common reference design. In such an experimental design
the labelling biases cancel themselves out in the calcula-
tion of the test statistic.
2. In [13], the biological variances of the two popu-
lations under comparison do not have to be the same,
that is, we did not assume σ2c = σ
2
t . For the t test in
this paper, we have made an additional assumption that
σ2c = σ
2
t . Relaxing this requirement was possible, as in
the case of the traditional two-sample t test with unequal
variance [14], but an exact power function could not be
readily obtained.
3. The exact power function obtained in this paper
allows evaluation of the effects of pooling biological sam-
ples and the effects of taking multiple technical measure-
ments, thus giving researchers quantitative guidance on
the practice of pooling samples.
4. By setting the parameters r = 1 and m = 1, an
exact power function is provided for the traditional two-
sample t test with equal variance.
IV. RESULTS
We have implemented the computation of the power
function S of Eq.(12) as a Java application, which can
be accessed at the URL given in the abstract. Here we
apply this to microarray comparative studies for finding
differentially expressed genes, and investigate the effect
of pooling RNA samples in the experiments. We also
compare our exact results with some approximate results
presented by other authors [9] to demonstrate why an
exact formula is desirable.
A. Comparison with approximate results
Based on their approximate formulas, Shih et al. con-
sidered two scenarios to compare the number of bio-
logical subjects and number of microarrays in the non-
pooled and pooled designs[9]. Here we give exact re-
sults for the two scenarios to show the difference to
the approximate results. In the first scenario, we con-
sider that the common biological variance of the two
populations is σ2 = 0.05, and the technical variance
σ2ǫ = 0.0125, which gives the biological-to-technical vari-
ance ratio λ = σ2/σ2ǫ = 4. The preset target of the
experiment in this scenario is that the false positive rate
being controlled at Pth = 0.001 and the power being no
less than S = 0.95 to detect a two-fold differential gene
expression, which corresponds to µ = 1 with base 2 log-
arithm [9]. In Table I, we present results for different
pooling parameter r. It can be seen from the first panel
of this Table that in order to hit the preset target, the
non-pooled design (r = 1) requires at least 12 biologi-
cal subjects divided evenly to the two populations, i.e.,
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FIG. 1: The power S as a function of the total number of
pools nc+nt. The parameters used are for the second scenario
σ2 = 0.2, σ2ǫ = 0.05, λ = σ
2/σ2ǫ = 4, Pth = 0.001, µ = 1, and
m = 1. The five solid curves correspond to different levels of
pooling, from right to left, r = 1, r = 2, r = 4, r = 6, and
r = 15 respectively. The dashed line indicates the 95% power,
the intersections of which with the power curves specify the
total numbers of pools (assuming nc = nt) needed to achieve
the target power. The total number of biological subjects and
the total number of arrays can then be calculated simply by
Ns = r(nc + nt), and Nm = m(nc + nt) respectively.
6 from each of the two populations. Having 7 subjects
from one population and 5 subjects from the other is in-
sufficient to achieve the target of 95% detection power.
The effects of other levels of pooling on the detection
power are also shown in Table I. The minimum number
of biological subjects (Ns) and microarrays (Nm) that
meet the preset targets are highlighted with bold fonts.
It is clear that as the level of pooling is increased (with
increasing r), the number of microarrays Nm can be re-
duced, but the number of biological subjects Ns has to
be increased. For example, in order to reduce the num-
ber of arrays from 12 (Table I, first panel) to 8 (Table I,
fourth panel), the number of biological subjects to form
the pools must be increased from 12 to 40.
For the second scenario we consider the case σ2 = 0.2,
σ2ǫ = 0.05, which gives λ = σ
2/σ2ǫ = 4. Again the preset
targets are to detect a true differential expression µ = 1
with no less than 95% power while the false positive rate
is set at Pth = 0.001. Using these parameters, the power
S as a function of nc+nt is plotted in Fig.1 for different
levels of sample-pooling. For the non-pooled design (r =
1), Ns = 30 total biological subjects and Nm = 30 arrays
are required to hit the preset targets. Similar to the first
scenario, as the level of pooling is increased, the number
of arrays Nm is reduced while the number of subjects
increased to meet the preset targets.
In Table II, we summarize our exact results and the
approximate results of [9]. It can be seen that the differ-
ence between the two can be very large, indicating the
need for exact results. For example, in the first scenario
5when Nm = 8 the approximate result of [9] predicts that
a minimum of 21 biological subjects are required. In
practice 24 subjects are required as 24 is the minimum
number larger than 21 and divisible by 8. However this
experiment setup (24 subjects forming 8 pools, 8 microar-
rays) will only give a detection power of 90%. To meet
the target power of 95%, 40 biological subjects are actu-
ally required by our exact result. If an experiment with
Nm = 7 microarrays is planned, Shih et al. predicts that
37 subjects are required[9], but in fact 126 subjects must
be used to achieve the target. Generally, the approxi-
mate formulas of [9] are too optimistic in assessing the
benefits of pooling samples and reducing the number of
microarrays, because they underestimate the number of
biological subjects required.
B. Cost analysis
Depending on the material costs involved in the bi-
ological subjects and microarrays, the conditions where
pooling samples becomes beneficial may be different from
lab to lab. Here we show examples to determine these
conditions. Denoting the cost associated with each bio-
logical subject as Cs (including materials and labor etc)
and the cost associated with a microarray as Cm, then
the total costs for an experiment in microarray compar-
ative study is CT = NsCs + NmCm. Taking the first
scenario as an example, the total cost of a non-pooled
design to achieve our preset targets is
CT (r = 1) = 12Cs + 12Cm,
and the total cost for pooled design with r = 2 is
CT (r = 2) = 20Cs + 10Cm.
Therefore in order that the pooled design with r = 2 is
beneficial we must have
CT (r = 2) ≤ CT (r = 1), (13)
which requires that Cm ≥ 4Cs. Put another way, only
when the cost associated with one microarray Cm is more
than 4 times the cost of a subject Cs, does the pooling
design with r = 2 become preferable to the non-pooled
design. Similarly a higher level of pooling with r = 3
becomes preferable to r = 2 only when Cm ≥ 7Cs. Fur-
thermore the conditions for increasing the level of pooling
from r = 3 to r = 5 are Cm ≥ 13Cs, and so on. Table II
gives these conditions for further levels of pooling.
For the first scenario using the actual cost figures given
in [9] where Cs = $230 and Cm = $300, it can be seen
that none of the pooling conditions is met. Therefore
for this laboratory pooling samples is not recommended.
However, if we use the cost figures of [10] where Cs = $50
and Cm = $700, an optimal design is a pooled design with
r = 5.
For the second scenario, it is a similar story. The cost
figures of Ref. [9] (Cs = $230 and Cm = $300) gives
Cm = 1.30Cs, which does not satisfy any of the pooling
conditions. So again the non-pooled design with Nm =
30 and Ns = 30 is recommended. On the other hand,
the cost figures of [10] (Cs = $50 and Cm = $700) give
Cm = 14Cs which satisfies all the pooling conditions in
the lower panel of Table II except the last row. So in
Kendziorski et al’s lab, the pooled design with Nm = 14
and Ns = 84 would be recommended.
V. DISCUSSION
We have in this paper presented exact formulas for
calculating the power of microarray experimental design
with different levels of pooling. These formulas can be
used to determine the conditions of statistical equivalence
between different pooling setups. As in [10] and [9], the
calculations presented in this paper are for an individual
gene, so the statistical equivalence for different designs
of pooling can be determined with regard to one par-
ticular gene. However, microarray monitors thousands
of genes simultaneously, and the biological and techni-
cal variances vary from gene to gene, therefore no single
result of statistical equivalence between pooled and non-
pooled designs applies equally to all genes on the array.
So in practice how would the formulations in this work be
used? One possible way, as suggested by Kendziorski et
al. [10], is to specify the distributions of σ2 and σǫ and
calculate the total number of subjects and arrays that
maximize the average power across the the array. In the-
ory, if the biological variances and technical variances
were known for all genes on the array, an equivalence
condition between pooled and non-pooled designs could
be determined for each gene individually. The overall
(or say, average) equivalence condition between pooled
and non-pooled designs could be obtained, for example,
by some form of averaging operation over all genes. An
alternative and probably more practical way is to use
representative values of σ2 and σǫ. We therefore propose
that parameters for ”typical gene” be used as inputs for
the power and sample size calculations. A typical gene is
a gene whose biological and technical variance have the
most probable values among the genes, i.e., the mode
of the distribution for biological and technical variance
of genes. Alternatively, the median or mean variances
across genes could be used as representative values[9].
An issue associated with microarray experiments is the
problem of multiple inferences, where a separate null hy-
pothesis is being tested for each gene. Given thousands
of null hypotheses being tested simultaneously, the cus-
tomary significance level α = 0.05 for declaring positive
tests will surely give too many false positives. For ex-
ample, if among a total number N = 10000 of genes
being tested, N0 = 4000 are truly null genes (genes that
are non-differentially expressed between the two classes),
the expected number of false positive results would be
64000 × 0.05 = 200, which may be too many to be ac-
ceptable. Thus a smaller threshold p-value for declar-
ing differentially expressed genes should be used. Effec-
tively controlling false positives in a multiple testing situ-
ation such as microarray experiments is an area which has
drawn much attention in recent years due to the wider ap-
plication of microarray technology. As discussed in our
previous work in [13], generally speaking, all different
multiple-testing adjustment methods eventually amount
to effectively setting a threshold p-value, and then reject-
ing all the null hypotheses with p-value below this thresh-
old. The classical Bonferroni multiple-testing procedure,
which controls family-wise error rate at α by setting the
threshold Pth = α/N , is generally regarded as being too
conservative in the microarray context. The FDR (False
Discovery Rate) idea, initially due to [15] in dealing with
the multiple testing problem, has now been widely ac-
cepted as appropriate to the microarray situation. Re-
cently, Efron [16] extended the FDR idea by defining fdr,
a local version FDR (local false discovery rate). When
planning microarray experiments in terms of power and
sample size calculation, the FDR of [15] is more appropri-
ate and convenient to use. There are now in the literature
a few slightly different variants of the definition of FDR
[15, 17, 18], but in essence it is defined as the propor-
tion of false positives among all positive tests declared.
To provide an interface between FDR and the formula-
tion in the previous sections, here we show that there is
a simple correspondence between controlling FDR and
specifying the traditional type I error rate and power.
Suppose that there are a total number N of genes being
monitored by microarray, so there will be N hypotheses
being tested, one for each gene. Suppose that a fraction
π0 of the N genes are true null genes, i.e., genes that
are non-differentially expressed between the two classes.
Given the type I error rate Pth, the expected number of
false positive tests is PthNπ0; Given the power S, the
expected number of non-null genes (truly differentially
expressed genes) that are declared positive is SN(1−π0).
So the FDR achieved by this setting is
FDR =
PthNπ0
PthNπ0 + SN(1− π0) =
Pthπ0
Pthπ0 + S(1− π0) .
(14)
Here π0 is an important parameter in controlling FDR,
for which several different methods of estimating this pa-
rameter have been proposed [13, 18, 19]. Especially the
method we presented in [13] is an accurate yet computa-
tionally much simpler algorithm than the one proposed
by Storey and Tibshrirani in [18]. With the interface
Eq.(14), FDR can be readily presented and incorporated
into the calculations.
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7TABLE I: For the first scenario described in the text, the de-
tection power of designs with different levels of pooling. The
r = 1 panel represents that of non-pooled design. Other pa-
rameter values are: σ2 = 0.05, σ2ǫ = 0.0125, λ = σ
2/σ2ǫ = 4,
and m = 1. Ns = r(nc + nt) is the total number of biological
subjects required, and Nm = m(nc+nt) is the total number of
measurements (microarrays) needed, counting both the con-
trol and the treatment populations. The preset targets are
false positive rate being controlled at Pth = 0.001, to detect
two-fold differential expression (µ = 1) with power no less
than 0.95. The minimum number of biological subjects (Ns)
and microarrays (Nm) that meet the preset targets are high-
lighted with bold fonts.
nc nt S r Ns Nm
5 5 0.8175 1 10 10
5 6 0.9026 1 11 11
6 5 0.9026 1 11 11
5 7 0.9488 1 12 12
7 5 0.9488 1 12 12
6 6 0.9553 1 12 12
6 7 0.9796 1 13 13
7 6 0.9796 1 13 13
3 3 0.3012 2 12 6
3 4 0.5555 2 14 7
4 3 0.5555 2 14 7
3 5 0.7602 2 16 8
5 3 0.7602 2 16 8
4 4 0.7937 2 16 8
4 5 0.9196 2 18 9
5 4 0.9196 2 18 9
5 5 0.9771 2 20 10
3 3 0.4060 3 18 6
3 4 0.6962 3 21 7
4 3 0.6962 3 21 7
3 5 0.8774 3 24 8
5 3 0.8774 3 24 8
4 4 0.9008 3 24 8
4 5 0.9745 3 27 9
5 4 0.9745 3 27 9
5 5 0.9957 3 30 10
2 2 0.0444 5 20 4
2 3 0.1930 5 25 5
3 2 0.1930 5 25 5
2 4 0.4732 5 30 6
4 2 0.4732 5 30 6
3 3 0.5324 5 30 6
3 4 0.8262 5 35 7
4 3 0.8262 5 35 7
4 4 0.9657 5 40 8
2 2 0.0643 18 72 4
2 3 0.2994 18 90 5
3 2 0.2994 18 90 5
2 4 0.6718 18 108 6
4 2 0.6718 18 108 6
3 3 0.7309 18 108 6
3 4 0.9515 18 126 7
4 3 0.9515 18 126 7
4 4 0.9969 18 144 8
8TABLE II: Comparison of our exact results and the approxi-
mate results of Ref. [9]. The upper panel of the table is for the
first scenario, where σ2 = 0.05, σ2ǫ = 0.0125, λ = σ
2/σ2ǫ = 4.
The lower panel is for the second scenario, where σ2 = 0.2,
σ2ǫ = 0.05, and λ = σ
2/σ2ǫ = 4. The targets of both scenarios
are that the false positive rate Pth = 0.001 and the power
no less than S = 0.95. The last column in each panel gives
the cost conditions when pooling samples become beneficial
relative to a lower level of pooling shown in this table.
Nm Ns Ns Conditons
(Exact) (Approx)
11 11
12 12
10 20 13 Cm ≥ 4Cs
9 27 16 Cm ≥ 7Cs
8 40 21 Cm ≥ 13Cs
7 126 37 Cm ≥ 86Cs
30 30
21 42 Cm ≥ 1.33Cs
22 35
16 64 50 Cm ≥ 4.4Cs
14 84 64 Cm ≥ 10Cs
12 180 104 Cm ≥ 48Cs
